Skip to content

ADVIA Centaur aHBe2 50T Kit 10720831Recalls & reported problems

Siemens Healthcare Diagnostics Inc. · Anti-HBe2 (aHBe2) – ADVIA Centaur – RGT 50T · Class 2

Data updated Oct 18, 2026 from official FDA records · Editorial policy

1 open recall names this device. See the recall details and contact the manufacturer or your healthcare provider.

Adverse event reports
0
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

No MAUDE adverse event reports in our data reference this device identifier directly.

1 FDA recall record name this device's identifier, 1 still open.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Dec 22, 2022Class IIOpen, Classified

    Anti-HBe2 (aHBe2) interference with the Hepatitis B e Antigen (HBeAg) Assay, leads to elevated or reactive Hepatitis B e Antigen (HBeAg) results on samples that are non-reactive when HBeAg testing follows aHBe2 testing, regardless of whether both tests are performed on the same sample

    Z-1143-2023 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Other Qualitative and Quantitative Hepatitis B Virus Antibody assays devices

All Qualitative and Quantitative Hepatitis B Virus Antibody assays devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page